These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2935550)

  • 21. A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer.
    Izuo M; Yoshida M; Tominaga T; Abe O; Enomoto K; Nomura Y; Kubo K; Takatani O
    Cancer; 1985 Dec; 56(11):2576-9. PubMed ID: 2932213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer].
    Kadota K; Wada T; Watatani M; Houjou T; Mori N; Yasutomi M
    Gan To Kagaku Ryoho; 1991 May; 18(6):983-7. PubMed ID: 1827574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative gas-liquid chromatographic determination of medroxyprogesterone acetate in human plasma.
    Rossi E; De Pascale A; Negrini P; Frigerio A; Castegnaro E; Castegnaro E
    J Chromatogr; 1979 Feb; 169():416-21. PubMed ID: 536431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid method for the determination of 5 alpha-dihydrotestosterone in Thai males receiving medroxyprogesterone acetate.
    Werawatgoompa S; Dusitsin N; Sooksamiti P; Leepipatpaiboon S; Virutamasen P; Boonsiri B
    Contraception; 1982 May; 25(5):523-33. PubMed ID: 6213376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MPA at high doses in advanced breast cancer: a statistical evaluation.
    Pannuti F; Camaggi CM; Strocchi E; Martoni A
    Chemioterapia; 1986 Jun; 5(3):159-63. PubMed ID: 2941172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Embryotoxicity of a single dose of medroxyprogesterone acetate (MPA) and maternal serum MPA concentrations in cynomolgus monkey (Macaca fascicularis).
    Prahalada S; Carroad E; Cukierski M; Hendrickx AG
    Teratology; 1985 Dec; 32(3):421-32. PubMed ID: 2934853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation.
    Johansson ED; Johansen PB; Rasmussen SN
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):311-7. PubMed ID: 2943134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial.
    Jakobsen A; Frederiksen PL; Møller KA; Andersen AP; Brincker H; Dombernowsky P; Hansen PV; Hesselius I; Kjaer M
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1067-72. PubMed ID: 2946583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bioavailability of an orally administered medroxyprogesterone acetate suspension.
    Antal EJ; Gillespie WR; Albert KS
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):257-9. PubMed ID: 6222996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
    Lundgren S; Lønning PE; Aakvaag A; Kvinnsland S
    Cancer Chemother Pharmacol; 1990; 27(2):101-5. PubMed ID: 2249324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
    Lundgren S; Lønning PE
    J Steroid Biochem; 1990 Jun; 36(1-2):105-9. PubMed ID: 2141886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative determination of medroxyprogesterone acetate in plasma by liquid chromatography/electrospray ion trap mass spectrometry.
    Kim SM; Kim DH
    Rapid Commun Mass Spectrom; 2001; 15(21):2041-5. PubMed ID: 11675672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An enzyme linked immunosorbent assay (ELISA) for plasma medroxyprogesterone acetate (MPA).
    Lewis LK; Elder PA; Barrell GK
    J Steroid Biochem Mol Biol; 1992 Apr; 42(2):179-83. PubMed ID: 1533148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chemiluminescence enzyme immunoassay (CLEIA) for the determination of medroxyprogesterone acetate in human serum.
    Kim JK; Adam A; Loo JC; Ong H
    J Pharm Biomed Anal; 1995 Jun; 13(7):885-91. PubMed ID: 8562612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology.
    Tamassia V; Battaglia A; Ganzina F; Isetta AM; Sacchetti G; Cavalli F; Goldhirsch A; Brunner K; Bernardo G; Robustelli della Cuna G
    Cancer Chemother Pharmacol; 1982; 8(2):151-6. PubMed ID: 6213319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The plasma concentration of medroxyprogesterone acetate and ovarian function during treatment with medroxyprogesterone acetate in 5 and 10 mg doses.
    Wikström A; Green B; Johansson ED
    Acta Obstet Gynecol Scand; 1984; 63(2):163-8. PubMed ID: 6233840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast.
    Canney PA; Dowsett M; Priestman TJ
    Br J Cancer; 1988 Jul; 58(1):73-6. PubMed ID: 2971386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phase II study of medroxyprogesterone acetate in advanced breast cancer].
    Ueno K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ito Y; Imajo K; Ozeki H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3198-202. PubMed ID: 2946264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen.
    Becher R; Miller AA; Höffken K; Gerhold U; Hirche H; Schmidt CG
    Cancer; 1989 May; 63(10):1938-43. PubMed ID: 2522811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
    Dowsett M; Lal A; Smith IE; Jeffcoate SL
    Br J Cancer; 1987 Mar; 55(3):311-3. PubMed ID: 2952154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.